Warts-and-all trials
The International Committee of Medical Journal Editors has warned drug firms that to qualify for publication, clinical trials must in future be registered before they begin. The ruling, effective from 1 July, is meant to stop companies suppressing poor or adverse results. “We think the public deserves to know about trials that could shape the body of evidence about clinical effectiveness or adverse effects,” says a committee statement in The New England Journal of Medicine (vol 352, p 2436).
Home for retired tigers
India is planning a 45-hectare “care home” for ageing Royal Bengal tigers in the…
